Cramer cites falling rates as key market driver, highlights non-tech growth and tech hurdles
Summary
Jim Cramer argues that interest rates, influenced by oil prices, are the primary market mover, benefiting non-tech sectors like medical devices and financials while pressuring tech stocks. He identifies four hurdles for tech recovery: technical indicators, hyperscaler earnings stability, midterm elections, and the Anthropic IPO. Cramer also discusses fashion stocks, Nike's potential rebound, and Disney's outlook under new leadership. The episode features an interview with Hinge Health's CEO regarding strong earnings and cost-saving benefits, followed by a lightning round and analysis of major mergers involving Marvell and Kimberly-Clark.
Key takeaways
- 1 Specifically, we've seen a number of important stocks where the 50-day moving average has crossed below the 200-day 200 day moving average, and an event that's dramatically known as the death cross. Now I have never told you to sell a stock just because you've seen this chart, but I do want to bring it out that we're seeing it in a Broadcom, GE Vernova, Alphabet, and this is very telling, okay?
Unidentified speaker (speaker_3) · 16:16
- 2 Revenue in the third quarter jumped 52% to $235 million, beating expectations.
Unidentified speaker (speaker_3) · 33:39
Episode sections
- 1:22 – 4:38
Market Drivers and Tech Rotation
Jim Cramer argues that interest rates, driven by oil prices, are the primary market mover, causing non-tech stocks to rally while tech faces selling pressure. He notes that bonds lead stocks and that lower rates have benefited sectors like waste management and medical devices.
- 4:38 – 15:16
Non-Tech Growth Opportunities
Cramer highlights medical devices, financials, staples, and retailers as beneficiaries of falling rates. He specifically mentions Medtronic, Capital One, and Walmart as examples of growth stocks outside of tech performing well due to the rate environment.
- 15:16 – 24:09
Tech Sector Analysis and Hurdles
Cramer outlines four hurdles for tech stocks to recover: technical improvements, hyperscaler earnings stability, midterm election resolution, and a successful Anthropic IPO. He notes that none have been fully cleared, leaving tech under pressure.
- 24:09 – 31:27
Wall Street Fashion Show
In a segment honoring his late nephew, Cramer reviews fashion stocks including Ralph Lauren, Tapestry, Levi's, VF Corp, Kontoor Brands, and Reformation, citing improved fundamentals, buybacks, and brand momentum as key drivers.
- 31:27 – 32:17
Nike Stock Analysis
Jim Cramer discusses Nike, noting the stock has dropped 40% and is 'washed out.' He suggests that while downside risk may be limited, upside potential exists if the company performs well, recommending investors bet with the stock rather than against it.
- 32:17 – 33:09
Disney Outlook and Consumer Retail
Cramer expresses optimism about Disney under CEO Josh D'Amaro, citing potential strength in the cruise line business if gasoline prices remain low. He also identifies consumer retail stocks as a favorable sector outside of tech.
- 33:09 – 40:55
Hinge Health Earnings and Interview
The segment covers Hinge Health's strong Q3 results, including a 52% revenue jump to $235 million and a beat on earnings. Cramer interviews CEO Daniel Perez about the company's technology-driven physical therapy model, cost-saving ROI for employers, and expansion into migraine care via the ENSO device.
- 40:55 – 45:01
Lightning Round: Market Views
Cramer gives rapid-fire opinions on several stocks. He likes Johnson & Johnson under CEO Joaquin Duado, dismisses Nebius as not high-quality, avoids buying falling semiconductor stocks like Lam Research, likes Hawk Aerospace, and prefers Micron over Western Digital.
- 45:01 – 49:42
Merger Analysis: Marvell and Kimberly-Clark
Cramer analyzes two major deals. He supports Marvell's $115 billion acquisition of Lumentum for data center connectivity despite 'merger purgatory,' citing CEO Matt Murphy's track record. He also praises Kimberly-Clark's $48.7 billion acquisition of Kenvue, noting the bargain price due to political pressure on Tylenol.
Assets discussed
| Asset | Kind | Stance | Context |
|---|---|---|---|
| AmazonAMZN | equity | bullish | Take Amazon. We were out adamant of it last week when we told club members not to fret. Despite the negative response. Friday, Amazon's quarter was actually a very good one. |
| AppleAAPL | equity | neutral | Now, after the close tonight, Apple reported they delivered its first quarter with new CEO John Turners at the helm. They gave us the same consistent result we've come to expect from what is now once again the world's largest company. Apple delivered a record September quarter to cap capital off for a record year, with a top and bottom might be driven by strong iPhone and Mac max sales. And by the way, you got it from me. An excellent sales performance in China. But you know what? There's still some things that people don't want. And remember, I told you the stock came in real hot. Investors were watching closely to see if there'd be a degradation in the company's gross margins, thanked skyrocketing memory prices. Now, luckily there was not. Gross margins came in well above expectations through tariff refunds helped on that front. Now, Apple usually gives us some cost. color on the outlook on its earnings call. Uh so far it looks like it's not that positive, but we'll see what the market has to say about it tomorrow. We're eager for some positive commentary about strong demand for the iPhone Duo, but not too strong demand. I am sure we'll get it and hope that there's no landmines for commentary on memory. But this was another great quarter from what is easily the best performing large cap tech stock of 2026. Remember though, what matters is not the previous quarter, it is the future. It is the guidance, and that is not, I've been telling club members, going to be as good as Apple shareholders want it to be. I have said over and over again, short term, I expect the stock to go down. |
| Nasdaq Composite | index | neutral | If you're looking at the charts of the broader indices, the Nasdaq Composite, NASDAQ 100, even key tech indices, uh subsector indices like the Philadelphia Semiconductor. |
| AlphabetGOOGL | equity | neutral | Now I have never told you to sell a stock just because you've seen this chart, but I do want to bring it out that we're seeing it in a Broadcom, GE Vernova, Alphabet, and this is very telling, okay? |
| MicrosoftMSFT | equity | neutral | In fact, but as we explained on Friday night, the bad news is that the only hyperscalers that did dial back its CapEx plans, Microsoft, Off saw the best reaction from the market for doing so. |
| S&P 500 | index | neutral | Since bottoming in late 2022, Ralph Lawrence shares have rallied an astonishing 380% for the low, compared to roughly 110% gain for the SP 500 during this period. |
| JOHNSON & JOHNSONJNJ | equity | mixed | Hey uh my family and I have both worked and invested in Johnson Johnson for about 30 years and always been happy with the company. |
| KLA CORPKLAC | equity | bullish | Jim, listen, KLA Corp has got a 10-year kager of 30%. The stocks recently have been down, but what's interesting is that it specializes in optical wafer uh equipment, which is, you know, everyone knows there's a full market going on in optical, and I think that's a that should continue to fuel growth for KLA. |
| NVIDIANVDA | equity | neutral | Hey, look, never forget that Jensen Wong, the CEO of NVIDIA, anointed Marvell as the next trillion dollar company and Matt intends to fulfill that promise. |
“Stance” is how the speakers talked about the asset, not a recommendation.
Claims worth verifying
Amazon employees in Canada earn an average of over $26 an hour and have access to free skills training in software development and IT.
Unidentified speaker (speaker_0) ·0:01
How to verify: Check Amazon's Canadian careers page or press releases regarding employee compensation and training programs in Canada. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
The Dow finished up 214 points, while the NASDAQ slid 1.07% lower.
Unidentified speaker (speaker_3) ·2:06
How to verify: Check historical market data for the trading day on November 2, 2026, from a financial data provider like Bloomberg or Yahoo Finance. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Amazon's operating income result was a massive beat, though EPS was distorted by investments.
Unidentified speaker (speaker_3) ·3:38
How to verify: Review Amazon's Q3 2026 earnings report filed on SEC EDGAR, specifically the income statement and management discussion. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceWaste Management (WM) gained four points on the day.
Unidentified speaker (speaker_3) ·4:38
How to verify: Check WM's stock price movement on November 2, 2026, and its Q3 2026 earnings report for context. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
IDEX Labs led the S&P 500 with a 22% gain after reporting great results.
Unidentified speaker (speaker_3) ·5:11
How to verify: Review IDEX's Q3 2026 earnings report and check its stock price change on November 2, 2026. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceCapital One roared nearly 3% higher as rates went down.
Unidentified speaker (UNKNOWN) ·5:31
How to verify: Check Capital One's stock price movement on November 2, 2026, and its recent earnings reports for credit delinquency data. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
American Express soared nearly nine points.
Unidentified speaker (speaker_3) ·5:32
How to verify: Check American Express's stock price movement on November 2, 2026. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Marvell Technology decided to merge with Lumentum in a $115 billion deal.
Unidentified speaker (speaker_3) ·7:51
How to verify: Review the joint press release or SEC filings (Form 8-K) from Marvell and Lumentum regarding the merger agreement. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceOracle filed to raise $20 billion, half from stocks and half from bonds.
Unidentified speaker (speaker_3) ·8:36
How to verify: Check Oracle's SEC filings (Form S-3 or Form 8-K) for the registration of securities for the $20 billion offering. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceApple delivered a record September quarter with strong iPhone and Mac sales.
Unidentified speaker (speaker_3) ·9:07
How to verify: Review Apple's Q4 2026 earnings report filed on SEC EDGAR. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceNike stock is down 40% and analysts have turned in.
Unidentified speaker (speaker_3) ·31:33
How to verify: Check Nike (NKE) stock price history for the period leading up to the broadcast date (Nov 2026) and review analyst rating changes in financial news archives. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Disney cruise line business could see better numbers if gasoline prices go down.
Unidentified speaker (speaker_3) ·32:29
How to verify: Review Disney (DIS) earnings reports and cruise segment performance data correlated with historical gasoline price indices. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Hinge Health Q3 revenue jumped 52% to $235 million.
Unidentified speaker (speaker_3) ·33:39
How to verify: Access Hinge Health's Q3 2026 earnings press release or SEC 8-K filing. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceHinge Health earnings came in 13 cents ahead of estimates.
Unidentified speaker (speaker_3) ·33:59
How to verify: Compare Hinge Health's reported EPS in its Q3 2026 earnings release against consensus analyst estimates from financial data providers. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Hinge Health received FDA clearance for its migraine ENSO device in April.
Unidentified speaker (UNKNOWN) ·37:50
How to verify: Search the FDA's database for 510(k) clearances or De Novo decisions for Hinge Health's migraine device issued in April 2026. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Hinge Health demonstrated a 23% reduction in monthly migraine days and a 28% reduction in attack length.
Unidentified speaker (speaker_0) ·38:30
How to verify: Review Hinge Health's published clinical data or press releases detailing the efficacy results of the ENSO device. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Johnson & Johnson is getting rid of its commodity-based synthetic joint business.
Unidentified speaker (speaker_3) ·41:33
How to verify: Check Johnson & Johnson (JNJ) investor presentations or press releases regarding the divestiture of its orthopedics or synthetic joint assets. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceMarvell Technology is acquiring Lumentum for $115 billion.
Unidentified speaker (UNKNOWN) ·45:01
How to verify: Review the definitive merger agreement filed by Marvell (MRVL) and Lumentum (LITE) with the SEC. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceKimberly-Clark acquired Kenvue for $48.7 billion.
Unidentified speaker (speaker_3) ·46:51
How to verify: Check Kimberly-Clark (K) investor materials or SEC filings for the acquisition of Kenvue (KVUE). For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Primary sourceRobert F. Kennedy Jr. made claims about Tylenol increasing autism risk, causing Kenvue's stock to drop.
Unidentified speaker (speaker_3) ·47:23
How to verify: Search news archives for statements by Robert F. Kennedy Jr. regarding Tylenol and autism, and correlate with Kenvue stock price movements during the relevant period. For recent events, verify 2026-08-03 through 2026-11-03. Use another period only when the speaker explicitly names it.
Do your own research
- Verify the 30-year treasury yield trend and its historical correlation with S&P 500 performance using FRED data.
- Check the latest 10-K and 10-Q filings for Waste Management, Capital One, and American Express to confirm earnings and rate sensitivity.
- Review technical charts for Broadcom, GE Vernova, and Alphabet to confirm the 'death cross' status.
- Analyze Microsoft's latest earnings call transcript for details on AI CapEx guidance and investor sentiment.
- Examine Nike's recent quarterly reports and management commentary on inventory levels and consumer demand trends.
- Verify Hinge Health's Q3 earnings release and FDA clearance documentation for the ENSO device.
- Review the SEC filings for the Marvell-Lumentum and Kimberly-Clark-Kenvue mergers for deal terms and regulatory status.
Full transcriptexpand
- 0:00
- Unidentified speaker (UNKNOWN): In
- 0:01
- Unidentified speaker (speaker_0): communities across Canada, hourly Amazon employees earn an average of over $26 an hour. Employees also have the opportunity to grow their skills and their paycheck by enrolling in free skills training programs for in-demand fields like software development and information technology.
- 0:22
- Unidentified speaker (speaker_0): Learn more at about aboutAmazon.ca. Amazon.ca
- 0:30
- Unidentified speaker (speaker_1): How does Edward Jones do money differently?
- 0:33
- Unidentified speaker (speaker_2): Our financial advisor would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
- 0:42
- Unidentified speaker (speaker_3): Knowing our financial advisor was always there. We could can call him with anything at any time.
- 0:49
- Unidentified speaker (speaker_1): We do money differently. by providing advice that actually fits you.
- 1:00
- Unidentified speaker (UNKNOWN): My
- 1:01
- Unidentified speaker (speaker_1): mission is simple. To make you money. I'm here to level the playing field for all investors. There's always a bull market somewhere, and I promise to help you find it. Mab Mad Money starts now.
- 1:17
- Unidentified speaker (UNKNOWN): Hey,
- 1:17
- Unidentified speaker (speaker_1): I'm Kramer. Welcome to MAB Money. Welcome to Kramerica.
- 1:22
- Unidentified speaker (UNKNOWN): Look
- 1:23
- Unidentified speaker (speaker_3): at my friends. I'm just trying to save a little money. My job is not just to teach, but to also entertain. Call me 1 800 743 CNBC. Tweet me at Jim Kramer. Never forget what this market's really about oil, inflation, interest rate. rates. Sure, there's some stocks that rallied that had nothing to do with that
- 1:42
- Unidentified speaker (speaker_3): combination. Uh, but I've got to tell you, without any other quality, those are the ones that move things. The main story today was that oil plummeted overnight on hopes for a peaceful ending of the war, which sent interest rates lower and then caused cause a host of stocks to soar, at least initially in some cases. By the end of the day, we saw a
- 2:02
- Unidentified speaker (speaker_3): fresh wave. of tech selling.
- 2:04
- Unidentified speaker (UNKNOWN): Sell, sell, sell. So
- 2:06
- Unidentified speaker (speaker_3): the Dow finished up 214 points. Remember, there's not a lot of tech in the Dow. SB fell 0.51%,
- 2:12
- Unidentified speaker (speaker_3): but the NASDAQ slid 1.07% lower. It's getting exhausting, isn't it?
- 2:19
- Unidentified speaker (UNKNOWN): Well,
- 2:20
- Unidentified speaker (speaker_3): I like to tell the story of when I worked at Goldman Sachs, where I was often on the road. I wanted to know what the market was doing, so I called in. I used to ask for prices of a whole bunch of stocks. Oh man, I was a real pain in the butt. But my colleagues over time warmed me down by saying, Well, only the only thing you need is what the long bomb was doing, the long bomb meaning the 30-year treasury.
- 2:38
- Unidentified speaker (UNKNOWN): And
- 2:38
- Unidentified speaker (speaker_3): then I didn't really need any more information. They were dismissive of me. Okay, I can deal with that. If the long bomb was up in price and down in yield, then it was likely that the stocks that I liked were asking about were higher that day. If it was down in price and up in yield, then the stocks I asked were probably lower. My colleagues, you know what? As dismissive as they were, they were
- 2:58
- Unidentified speaker (speaker_3): right. Bonds lead stocks, not the other way around. Unfortunately, because of the negative nature of analysts and journals, it's never as big a story when rates go lower as it is when rates go higher. The 30-year heading back toward 5% five percent after a sojourn year six is has never played up as much as the opposite. story, which is the run from five to six. But today with
- 3:18
- Unidentified speaker (speaker_3): long rates coming down hard for most of the day, we saw a whole bunch of stocks rally as a as they probably should have when they first reported, but may have been overlooked because rates were rallying when they reported. In other words, interest rates were going higher when they reported, and people didn't look at the stocks or sold them. Take Amazon. We were out adamant of it last week when we told club members not to fret. Despite the negative
- 3:38
- Unidentified speaker (speaker_3): response. Friday, Amazon's quarter was actually a very good one. Sure, the company's still spending money on data centers in an aggressive way, but it had a massive beat with its operating income result, which just didn't flow through to the earnings per share number, because the latter is distorted by investments in different companies that Amazon had made. Now, I know many people are loathed to asterisk EPS to claim that the
- 3:58
- Unidentified speaker (speaker_3): bottom line some somehow L doesn't matter, but this one actually resonated with me, and we urged people to buy not sell. Sure enough, with a better rate backdrop today, we saw Amazon return to where it was in late September. Okay, maybe it's a one-off. Most detected didn't do that, but it's important to point out. Or how about you you might have sold this one we s when we had WM1, the old waste management? We had CEO Jim Fish uh uh just last week.
- 4:18
- Unidentified speaker (speaker_3): Results were superb. One more great quarter. This one has was, by the way, the final one before he retires at the end of the year. That great quarter was met with a muted response. The whole darn thing was quite quizzical. But rates have gone up and the market rendered a negative judgment. Today, with rates back under control, Dumb Ham gained four points. That is the interest rates talking and
- 4:38
- Unidentified speaker (speaker_3): the stock echoing that talk. If you can find a growth stock that's not a tech stock right now, you can really clean up. Right now, this market has crazy eyes for medical devices. That seems like a tech, but it's not traditional. tech. Medtronic is worked. Some GE healthier. Boy, that thing was a And don't forget, intuitive surgical, uh Abbott
- 4:58
- Unidentified speaker (speaker_3): Labs played catch up. The latter is so far behind the market that that could have some gas in the tank. IDEX Labs put out a great set of results this morning, and the veterinary lab company led the SP 500 with a magnificent Deficit gain of nearly 22%.
- 5:11
- Unidentified speaker (speaker_3): That's my kind of attack. tech. It's most pronounced though when you have. a financial. Last week was a brutal week for Capital One, the credit card company, and a double whammy. Investors were worried about high oil prices mean at the pump, as well as credit delinquencies as rates went higher. But with rates going down, the whole thing reverses and Capital One roars nearly 3%.
- 5:31
- Unidentified speaker (UNKNOWN): Hey,
- 5:32
- Unidentified speaker (speaker_3): wasn't American Express Quarter supposed is to be weak? Well, you sure couldn't tell that from today's action where it soared nearly nine points. JP Morgan's quarter was not appreciated until now, with the stock pushing up more than a percent today. The staples have been rallying endlessly, and they had still one more day of strength. But this time they went a little downscale. Papsico, it is previously
- 5:52
- Unidentified speaker (speaker_3): the market had shunned this one because uh GLP-1's and the sating, I always want to use that word, S E T-I-N-G, T I N G Sading saving of Potato Chips. There's been a lot of positive commentary, believe it or not, about liquid. liquor from the industry of late. Yes, the numbers actually have gotten better, particularly for beer. So once again, conservation brands, the beer, wine, and spirits company, gained another 4% in
- 6:12
- Unidentified speaker (speaker_3): an exaggerated move fueled by again rates. The growth retailers, oh man, do they do well when rates go lower? Walmart, Costco, whoa, why not? Rates lower, gasoline lower means more to disbanded spend inside their stores. The Fist stocks have stocks of general of Dollar General and Dollar Tree roared too. Both travel stocks
- 6:31
- Unidentified speaker (speaker_3): powered higher, led by Marriott, which is a had a tremendous set of numbers this morning. The cruise lines followed suit. They're always led by Royal Caribbean. Can you believe it? Yes. Almost every single one of these stocks, with the exception of Marriott and Idex Labs, had no news at all associated with their stocks. Investors simply can value them higher with interest rates uh off the boil. Now
- 6:51
- Unidentified speaker (speaker_3): I know you at home probably think this is a completely ridiculous concept. How can these stocks be worth more or less just because oil went down and took rates down with it? The answer lies with the beating heart of trading. Frankly, I find it ridiculous too. I'm like you. These exaggerated moves have nothing to do with uh most. that You know what they wait? Here's what they
- 7:11
- Unidentified speaker (speaker_3): are. They're just money sloshing around, a huge amount of money piling. into smaller stocks at the same time. They aren't sustainable moves, but in a market where money keeps pouring out of tech yet wants to stay in the market, the growth of these companies may be more substantial than anything coming out of tech. I will tell you that Pocker Gamble has staying power. I also think that Colgate has staying power.
- 7:31
- Unidentified speaker (speaker_3): Now, these are these stocks are just proxies for growth as tech stocks continue to lose its m its their luster. This morning Marvell Technology decided to merge with Lumentum in a $115 billion deal that will put together a custom semiconductor business and a laser company and create one of the top suppliers to the data center. You know what?
- 7:51
- Unidentified speaker (speaker_3): I think the deal is actually a good one. I'm not kidding. I thought it really made sense, it was intellectually rigorous, and I'm gonna praise it later in the show. But right now, the though the market just despises this deal. I mean like holy cow! It hates Marvell, which is one of the great compound annual growth companies in this year. This stock has been down more than 10% for
- 8:11
- Unidentified speaker (speaker_3): each of the last three trading days. That is abysmal.
- 8:16
- Unidentified speaker (UNKNOWN): The
- 8:16
- Unidentified speaker (speaker_3): Madragular Oracle, a serial capital raiser, came out last week and told people that it would limit capital raises to just 20 billion for the next three and a half years. Wow, yes! But after Oracle's stock rallied, on those combs, they came right back today and they filed to raise $20 billion, half from stocks, half from bonds. Um I call that poor form. Well, they said they had
- 8:36
- Unidentified speaker (speaker_3): they had to do it. Um but clearly investors didn't realize it was gonna be done right away. What what's Oracle scared of? Do they expect lower prices for the stock and they want to beat the sellers to the punch?
- 8:47
- Unidentified speaker (speaker_3): Great. And Intel went down again. People fret that tomorrow. we will learn that they aren't just a victim of a weak PC market, but instead are getting their butt kicked in PCs by AMD. Now, after the close tonight, Apple reported they delivered its first quarter with new CEO John Turners at the helm. They gave us the same consistent result we've come to expect from what is now once again the world's largest
- 9:07
- Unidentified speaker (speaker_3): company. Apple delivered a record September quarter to cap capital off for a record year, with a top and bottom might be driven by strong iPhone and Mac max sales. And by the way, you got it from me. An excellent sales performance in China. But you know what? There's still some things that people don't want. And remember, I told you the stock came in real hot. Investors were watching closely to see if there'd be a
- 9:27
- Unidentified speaker (speaker_3): degradation in the company's gross margins, thanked skyrocketing memory prices. Now, luckily there was not. Gross margins came in well above expectations through tariff refunds helped on that front. Now, Apple usually gives us some cost. color on the outlook on its earnings call. Uh so far it looks like it's not that positive, but we'll see what the market has to say about it tomorrow. We're eager for some positive commentary
- 9:47
- Unidentified speaker (speaker_3): about strong demand for the iPhone Duo, but not too strong demand. I am sure we'll get it and hope that there's no landmines for commentary on memory. But this was another great quarter from what is easily the best performing large cap tech stock of 2026. Remember though, what matters is not the previous quarter, it is the future. It is the guidance, and that is not, I've been telling club members, going to
- 10:07
- Unidentified speaker (speaker_3): be as good as Apple shareholders want it to be. I have said over and over again, short term, I expect the stock to go down. Here's the bottom line. It seems that almost any growth stock can rally with interest rates plummeting because of lower oil prices. But growth stocks, well, I away from tech, they're pretty darn good. And tech, they remain in purgatory, and if you stick with us, you will hear
- 10:27
- Unidentified speaker (speaker_3): what can break the pattern of endless selling in what was once everyone's favorite sector.
- 10:32
- Unidentified speaker (UNKNOWN): Let's
- 10:32
- Unidentified speaker (speaker_3): go to Dimitri in California, please. Dimitri.
- 10:36
- Unidentified speaker (UNKNOWN): Good
- 10:36
- Unidentified speaker (speaker_0): afternoon, Jim.
- 10:38
- Unidentified speaker (speaker_3): What's up?
- 10:39
- Unidentified speaker (UNKNOWN): I
- 10:40
- Unidentified speaker (speaker_0): have Bloom Energy. It was booming and booming and booming.
- 10:44
- Unidentified speaker (UNKNOWN): It had
- 10:45
- Unidentified speaker (speaker_0): a great quarter and then it just tanked. What is your prediction on Bloom Energy and
- 10:52
- Unidentified speaker (UNKNOWN): I'm
- 10:52
- Unidentified speaker (speaker_3): going to divide this into two things. Bloom Energy, I think, is the future. It creates this tremendous energy without combustion. But the stock went up huge because of that. And now it is repealing a lot of that move. I did a big piece this weekend for club members about the repealing of the great quarters.
- 11:12
- Unidentified speaker (speaker_3): I think that Bloom Energy is part of that great quarter. repeal. Let's go to Carl in Indiana. Carl.
- 11:19
- Unidentified speaker (speaker_0): Good evening, Mr. Kramer.
- 11:21
- Unidentified speaker (UNKNOWN): At
- 11:22
- Unidentified speaker (speaker_0): 83 years old, I'm concerned that my stock has reached the proverbial plateau. Plateau, and the only weight is down.
- 11:33
- Unidentified speaker (speaker_0): My stock is caterpillar.
- 11:36
- Unidentified speaker (speaker_3): Okay. Uh Caterpillar did not raise. estimates that people thought would be raised, and consequently, the stock has been going down. I think you should sell half tomorrow and then watch it. I am concerned, like you are. And I think when you have someone, when I hear someone who says, look, all it can do is go down, I want you
- 11:56
- Unidentified speaker (speaker_3): to cut some of it out. Uh is your age Does your age matter? You sound like a young guy. I don't care about that. I care about the fact that it's time to take something off the table and let the rest be run. And let's see where it goes. Right. It seems like any gross stock can rally if interest rates fall, any gross stock except for a tech stock that is. Oh
- 12:16
- Unidentified speaker (speaker_3): man, money tonight. What will it take for us to finally get a bottom in tech? I'm gonna lay out the top four targets. I'm watching. Then I keep saying you need to be finding positions outside of tech right now. I'm how highlighting one sector that's been on the upswing lately, and the names you can profit from it. And hey, speaking of tech that's not uh that's healthcare and not semis,
- 12:36
- Unidentified speaker (speaker_3): Hinge Health reported a terrific order tonight. I'm gonna get with the latest get the latest with the CEO. So stay with Kramer.
- 12:46
- Unidentified speaker (speaker_1): Don't miss a second of Mad Money. Follow at Jim Kramer on X. Have a question? Tweet Kramer. Hashtag Mad Mentions. Send Jim an email to madmoney at cnbc.com. Or give us a call at 1 800 743 CNBC. Miss something? Head to madmoney.cnbc.com.
- 13:12
- Unidentified speaker (speaker_2): Legendary has arrived in Alberta with BetMGM Casino. Sign up to unlock access to over 4,000 casino games, including exclusive slots you can't spin anywhere else. Survivors, ready? The iconic TV show is now an online casino game where you can tap into island fun. BetMGM has also brought the prices right, Game
- 13:32
- Unidentified speaker (speaker_2): of Thrones, Family Feud, MGM millions, and so many more exclusive
- 13:36
- Unidentified speaker (speaker_1): casino games to Alberta. Get Las Vegas right from your phone. with live dealer games streaming from real tables. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Casino and its legendary library of games are available. Download the BetMGM app. See BetMGM.com for terms. 18 plus Alberta only. Please play responsibly,
- 13:56
- Unidentified speaker (speaker_1): subject to eligibility requirements.
- 13:58
- Unidentified speaker (UNKNOWN): If
- 13:58
- Unidentified speaker (speaker_1): gambling is affecting your mental health or well-being, 211 Alberta is here to help. Call or text 211. or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta iGaming Corporation. Standard message and data rates may apply. How does Edward Jones do money differently?
- 14:14
- Unidentified speaker (speaker_2): Our financial advisor would listen to us
- 14:16
- Unidentified speaker (speaker_1): and
- 14:16
- Unidentified speaker (speaker_2): actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
- 14:23
- Unidentified speaker (speaker_0): Knowing our financial advisor was always there. We could call him with anything at any time.
- 14:30
- Unidentified speaker (speaker_1): We do money differently by providing advice that actually fits you.
- 14:41
- Unidentified speaker (speaker_3): AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future, they're shaping it. I'm Julia Borston, Senior. media and tech correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as AI reshapes the world.
- 15:01
- Unidentified speaker (speaker_3): Follow and listen to CNBC Changemakers, women leading in the age of AI, wherever you get your podcasts.
- 15:16
- Unidentified speaker (speaker_3): Tech stocks have been selling off hard for three straight weeks now. The Nasdaq 100 fell again today, and it's now nearly 11% off its early October highs. Big question is: is the worst of the tech sell off behind us, or is it safe to start shopping for deals at this point? Or look out below. And that's why tonight I want to
- 15:36
- Unidentified speaker (speaker_3): return to a rubric that I put forward two weeks ago. reviewing our progress against the four tangible hurdles that I gave you that I'd like to see cleared before I can feel better about tech. The first thing that I said was that we wanted to see an improvement in the technicals. That's the charts. They gotta get better. And that simply hasn't happened at all. If you're looking at the charts of the
- 15:56
- Unidentified speaker (speaker_3): broader indices, the Nasdaq Composite, NASDAQ 100, even key tech indices, uh subsector indices like the Philadelphia Semiconductor. Index, the SOX, you see the same thing: an ugly double top. And you know what? A double top almost always leads to lower prices. Worse, we're starting to see even more negative signs in charts of some
- 16:16
- Unidentified speaker (speaker_3): individual stocks. Specifically, we've seen a number of important stocks where the 50-day moving average has crossed below the 200-day 200 day moving average, and an event that's dramatically known as the death cross. Now I have never told you to sell a stock just because you've seen this chart, but I do want to bring it out that we're seeing it in a Broadcom, GE Vernova,
- 16:35
- Unidentified speaker (speaker_3): Alphabet, and this is very telling, okay? Very telling because there are a lot of people who live and die by the charts. Also when it comes to technicals for the market as a whole, the last thing that I'll note is that the market is not in the aggregate oversold, even as some text tech stocks have been slaughtered.
- 16:54
- Unidentified speaker (UNKNOWN): The
- 16:54
- Unidentified speaker (speaker_3): indicator that I use, the SPH short-range oscillator from Alpha Cold Market Edge, showed a reading of 1.1% in Friday's close. That's basically neutral. Actually, a little more overbought than oversold. This is because this hasn't been a true market-wide sell-off. Instead, it's been more of a rotation, with the pain more or less isolated to tech stocks, as we saw once again today. As I told you at the top of the show,
- 17:14
- Unidentified speaker (speaker_3): a lot of other stocks are acting sensibly in relation to the bond market. Next, the second thing I said we needed to see was the hyperscaler earnings reports. I want to see how they're doing. Simply I said I wanted to see no degradation of hyperscalers' huge tech spending plans. Now we have indeed gotten most hyperscalers' earnings reports at this point, but for the most part, they've gone the wrong
- 17:34
- Unidentified speaker (speaker_3): way. That is, if you're bullish from tech. The good news is that most of the large hyperscale hyperscalers are not dialing back to capital spending agendas. That gives us some hope that the AI infrastructure theme is not, in fact, dead.
- 17:49
- Unidentified speaker (speaker_3): In fact, but as we explained on Friday night, the bad news is that the only hyperscalers that did dial back its CapEx plans, Microsoft, Off saw the best reaction from the market for doing so. It didn't go up, of course, but it went down the least. and I'll take that in this lousy market. Just today we saw shares of Oracle get crushed. Oh my god, this was horrible. Another
- 18:08
- Unidentified speaker (speaker_3): obliteration, down 9%, uh round 9%. If the company launched a new $20 billion fundraising effort, $10 billion in equity and $10 billion in bonds. Tell pay for its data center spending, which seems endless. Oracle indicated last week that this could be coming sometime in the next three and a half years, but the market. clearly didn't expect it to come in
- 18:28
- Unidentified speaker (speaker_3): the next three days. They know nothing. Clearly the market has taken a new stance that's uh that's skeptical of major capital spending plans, especially if a company has to issue stock or new debt to pay for them. And that is something that we'll need to overcome somehow if we want to text tech stocks to rally. Oracle was really horrible today. It really just
- 18:48
- Unidentified speaker (speaker_3): caught a lot of people by surprise. The stock was up big on Friday. The third thing that I was looking for was simply a resolution to the midterm elections that we should get by Wednesday. While the consensus seems to be that a major success for the Democrats is a negative development for tech and the data center trade, I'm not sure it's as simple as that. First, the chance of Democrats making gains in
- 19:08
- Unidentified speaker (speaker_3): Congress has already likely been factored in at this point because the polls and prediction markets have been indicating this outcome for several weeks now. Frankly, I think it's just getting past this election. I think that's going to be the positive. A positive development even for tech stocks, because politicians who are opposed to data center will at least start quieting down about the issue. Could we see one more leg lower with a
- 19:28
- Unidentified speaker (speaker_3): big blue wave outcome? Maybe. And and we could also see more pain if the mid midterms are followed by an escalation of the war in Iran, as many suspect, although it wasn't. clear from the news today. I think we're near the end of the midterm election overhang. Uh I say by Thursday, by Thursday should look clearer. Finally, I
- 19:48
- Unidentified speaker (speaker_3): say that we need to see a successful anthropic IPO. And while that's also unresolved, there's been some nice progress in this front. This is the best one of the four. Last Monday the company released the S1 filing, which contained the IPO perspectives. Then today Anthropic released the updated S1 with even more detail, including third-quarter financial results. Those new numbers showed that revenue growth is still very strong, but
- 20:08
- Unidentified speaker (speaker_3): slowing. Anthropic's quarter-over-quarter revenue growth seems to have peaked in the second quarter at 144%, and it fell to 47% in the third quarter. On the other hand, the company's profitability, at least in an adjusted basis, has been improving throughout this year. We did not, as I was hoping for, get any details on October numbers. There'll be plenty of time to cover
- 20:28
- Unidentified speaker (speaker_3): more specifics from the anthropic perspectives. Don't worry, we're gonna cover it wall to wall. For now, what you need to know is that the deal is on track if all goes as planned. Roadshows should begin next week, and the IPO should price and begin trading in the third week of November.
- 20:44
- Unidentified speaker (speaker_3): And really, we don't care how well or poorly anthropic shares do after they price, we just want to see that there's enough demand for the IPO to. happen. In less consequential news, we learned that this weekend that Anthropic Rival OpenAI is lowering its ambitions for a new private fundraising round. After previously seeking to raise $30 billion at a $1.4 trillion valuation, it's now
- 21:04
- Unidentified speaker (speaker_3): looking to find $20 billion and it's cut its target valuation to $1.25 trillion, still pretty great. Some people throw it as a bad sign when it comes to investors' demand for AI labs at this point, but Enthropic
- 21:17
- Unidentified speaker (speaker_3): Here's the bottom line. A couple weeks ago I put forward four things that I'd like to see happen before I could feel more positive about tech stocks. None have gone our way thus far. So it's not surprising me the sector has remained under pressure. But if you're a tech optimist, the good news is we're approaching some potential turning points and the anthropic IPO keeps marching along. That's good. We need that deal to happen
- 21:37
- Unidentified speaker (speaker_3): if we want tech to get back on. track. Without it, expect many more days like the last few, where the most important tech stocks just cannot hold their gains. Mavone is back after the break.
- 21:51
- Unidentified speaker (speaker_3): Coming up, Kramer's
- 21:52
- Unidentified speaker (speaker_1): walking the catwalk and revealing his favorite stocks in the fashion sector. Next
- 22:02
- Unidentified speaker (UNKNOWN): year, the first time.
- 22:03
- Unidentified speaker (speaker_2): Legendary has arrived in Alberta with BetMGM Casino. Sign up to unlock access to over 4,000 casino games, including exclusive slots you can't spin anywhere else. Survivors, ready? The iconic TV show is now an online casino game where you can tap into island fun. BetMGM has also brought the prices right, Game
- 22:23
- Unidentified speaker (speaker_2): of Thrones, Family Feud, MGM millions, and so many more exclusive. casino games to Alberta. Get Las Vegas right from your phone with live dealer games streaming from real tables. And every time you play, you can enjoy instant deposit options and fast withdrawals. BetMGM Casino and its legendary library of games
- 22:40
- Unidentified speaker (speaker_1): are available. Download the BetMGM app. See BetMGM.com for terms. 18 plus Alberta only. Please play responsibly, subject to eligibility requirements. If gambling is affecting your mental health, or well-being, 211 Alberta is here to help. Call or text 211 or visit ab.211.ca. BetMGM operates pursuant to an operating agreement with the Alberta IGaming Corporation.
- 23:00
- Unidentified speaker (speaker_1): Standard message and data rates may apply. How does Edward Jones do money differently? Our financial advisor
- 23:06
- Unidentified speaker (speaker_2): would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in.
- 23:14
- Unidentified speaker (speaker_0): Knowing our financial advisor was always there. We could call him with anything at any time.
- 23:21
- Unidentified speaker (speaker_1): We do money differently by providing advice that actually fits you.
- 23:32
- Unidentified speaker (speaker_0): AI is here, transforming how we work, live, and lead. And the women I talk to aren't waiting for the future. they're shaping it. I'm Julia Borstin, Senior Media and Tech Correspondent at CNBC. This is CNBC Changemakers, where I talk with the female leaders transforming business as AI reshapes the world.
- 23:52
- Unidentified speaker (speaker_0): Follow and listen to CNBC Changemakers, women leading in the age of AI, wherever you get your podcasts.
- 24:09
- Unidentified speaker (speaker_3): Our mad money family
- 24:11
- Unidentified speaker (UNKNOWN): is
- 24:12
- Unidentified speaker (speaker_3): still missing Cliff Mason, my nephew, show's head writer for the past two decades, who left us far too early last month.
- 24:19
- Unidentified speaker (UNKNOWN): Kind
- 24:19
- Unidentified speaker (speaker_3): of miss everything about him, including the cliffisms that he used to regularly work into the show scripts that you probably heard and didn't know they were. his. These were go-to phrases which helped give this show kind of a signature sound, which was unlike anything else in the otherwise anodyne financial media. You know, but one of his favorites was he used to talk about the Wall
- 24:39
- Unidentified speaker (speaker_3): Street fashion show, which Cliff used to describe the fickle nature of investors.
- 24:47
- Unidentified speaker (speaker_3): Who can be obsessed with one theme or some stock one day, then hate it the next day? It was a call from metaphor that regular viewers have likely heard me say probably hundreds of times. So tonight, we're gonna pay some homage to Cliff and use one of his favorite phrases by bringing back the idea of the Wall Street fashion show. At least for an evening. But instead of talking about some specific theme that's in
- 25:07
- Unidentified speaker (speaker_3): or out of favor, like the semiconductors, I'm gonna use it for an actual fashion show.
- 25:13
- Unidentified speaker (UNKNOWN): See,
- 25:13
- Unidentified speaker (speaker_3): over the past few months, I've highlighted several fashion companies that I really like right now for various reasons. Many non tech areas of the market are continuing to do well, including a lot of consumer stocks. Meanwhile, there are some other things happening, like a major pullback in interest rates that are quite helpful for consumer names, as I talked about at the top of the show. As we approach the holiday gifting
- 25:33
- Unidentified speaker (speaker_3): season, these seem like good opportunities. So let's run through my favorite stories in the group, the Wall Street Fashion Show style. First, for the past couple of years, Ralph Lauren has been my favorite stock in the apparel sector. Under CEO Patrice LeVay, who's really pretty amazing, the company has pulled away from the pack, especially outperformed its peers, with its sales growing
- 25:53
- Unidentified speaker (speaker_3): at a 13% compound annual growth rate over the past five full fiscal years. Very hard to do, and its adjusted earnings per share growing at a 57% K Kager, Ger. okay, CAG UR component growth rate, during that period. Since bottoming in late 2022, Ralph Lawrence shares have rallied an astonishing 380% for the low, compared to roughly
- 26:12
- Unidentified speaker (speaker_3): 110% gain for the SP 500 during this period. Maybe it's not a Wall Street fashion show, maybe it's a maybe it's just something that's ingrained in our society. Ralph Lawrence's Lauren's performance performers has have been driven by consistent strength in the core North American market, but the company's seen absolutely growth overseas as well, particularly in Asia. Always strong in men's fashion, the classic American brand has also
- 26:32
- Unidentified speaker (speaker_3): found success in new end markets recently, accessories, outerwear, women's apparel. Company has focused on its DTC channels and cutting out brand dilutive wholesaler channels, which have really helped the improve the gross margins. I think they've helped the brand too. Ralph Lauren had a great quarter in early August, but after spiking in response to the quarter, Stocks had a big pullback in late August and
- 26:52
- Unidentified speaker (speaker_3): September, as all consumer names fell due to rising oil prices. It's since recovered, but you're basically getting that last quarter, which was really so good for free. Ralph Lauren reports again on Thursday morning. I'm hoping we get yet another strong result. I think we will. Also reporting on Thursday morning is Tapestry. That's the pairing parent company of
- 27:12
- Unidentified speaker (speaker_3): the Red Hot Coach brand, as well as the small smaller Kate Spade brand, which management is attempting to revitalize so far, not going all that well. Now, I spoke with Tapestry CEO Joanne Krevoiserat a couple of times this year. I really like the course story. I really do. Coach. Tapestry's found a niche in the accessible luxury lane with the brand's affordable
- 27:31
- Unidentified speaker (speaker_3): handbags, particularly well liked by younger female consumers consumer recently. That's it. Tapestry's last quarter in August was a major negative catalyst. TPR shares are down more than 20% since that report. Quota didn't seem that bad. It was the guidance. It was just in line, just in line. And for a stock that had roughly quadrupled over the past years, that wasn't good enough. I hope this
- 27:51
- Unidentified speaker (speaker_3): Thursday's report can represent the start of a comeback for Tapestry. Speaking of comebacks, have you seen the shares of Levi Strauss these past few weeks? When Levi's reported uh earnings in early October, the quarter was flawed. The mixed result with light sales, especially in the important GTC channel, with a bottom line beat because of mostly uh tariff refund refunds. The guide for
- 28:11
- Unidentified speaker (speaker_3): the next quarter was viewed as disappointing.
- 28:14
- Unidentified speaker (speaker_3): Levi's shares, which had already been declining throughout August, September, fell below $20 in the wake of that report. But Levi's Levi CEO, Michelle Goss, came on Ned there Monday the night of that report and took ownership of some mistakes that. the company had made. What a great honest interview that was. Basically, they didn't have enough product available for the most desired styles, like low-rise women's bottoms, which are
- 28:34
- Unidentified speaker (speaker_3): making a big comeback. But Levi's adjusted quickly, she said, and was in a good place going forward. That post-quarter dip was turned out to be a tremendous buying opportunity as Levi's shares have rallied over 20% from their lows over the past three weeks to $23 now. You know what the stuff
- 28:50
- Unidentified speaker (UNKNOWN): is?
- 28:50
- Unidentified speaker (speaker_3): stock's still cheap here, around 14 times earnings, 2.8% yield, significant buyback in place. I think this is a good option to play the broader strength in denim that we keep hearing about. Then there's two other comeback stories I really like in the fashion space. And I've been I've been speaking about them, but not enough. First is VF Corp and then the second one is Contour Brands. VF Corp is the
- 29:10
- Unidentified speaker (speaker_3): parent company of the North Face, Vans, Timberland, among other brands, and has been struggling. for a few years as the Vans brands language. But we're seeing signs that Vans are starting to gain momentum again, including a strong showing in the recent Piper Sandler team survey. VF Corp shares are up a quick 8% as I recommended the stock about two and a half weeks ago, thanks in large part to a strong
- 29:30
- Unidentified speaker (speaker_3): quarter last Wednesday. Now the Contour outdoor brand story is more about portfolio transformation. Currently, Contour owns the Wrangler and Lead. Denim brands, as well as Helly Hansen outdoor brand that it acquired last year. But it has announced a deal to sell the lead brand for up to $1 billion, which should close shortly, and will be followed by a large accelerated buyback plan. Going forward,
- 29:50
- Unidentified speaker (speaker_3): I like this combination of Wrangler to play the strength in denim and Heli Hansen, which is an underappreciated brand that should thrive as part of a larger company in Contour. Contor. KTB KTV shares are still relatively cheap, around about 15 times earnings, nearly 3% yield. sweeter. I think Kelly Hansen, by the way, I think their goods will propel the stock higher alone. Finally, how about a spec name in women's
- 30:10
- Unidentified speaker (speaker_3): fashion that people keep talking about to me when you're gonna talk about it? We keep talking about it, no one seems to listen. It's called Reformation, REF. I covered this recent IPO name at the end of September. It it hadn't done well out of the gate, but I checked it out after one of our callers asked us to look at it. I like what I saw. Reformation has great growth. It's profitable and has a differentiated shopping experience with a technology
- 30:30
- Unidentified speaker (speaker_3): kicker. Most importantly, some of the younger members of the MAB Money team assure me that the brand is cool. Ha! So I said I liked it, and as it turns out, I might have bottom ticked the stock. It's gained over 31% in October. Maybe it's better to be lucky than good. So there it is. That's our Wall Street fashion show. Ralph Lauren, Tapestry, Levi's, VF Corp, Contrabands,
- 30:50
- Unidentified speaker (speaker_3): and Reformation are some of the fashion stocks that I think look best right now. Cliff certainly would have written this segment better. He would have written everything better. But we hope he would have liked this one. Let's take some calls. Let's go to Rick in Wis Wisconsin. Rick.
- 31:07
- Unidentified speaker (UNKNOWN): Hi, Jim. Thanks
- 31:08
- Unidentified speaker (speaker_0): for taking my call.
- 31:09
- Unidentified speaker (speaker_3): Absolutely, Rick. What's going
- 31:11
- Unidentified speaker (UNKNOWN): on? I
- 31:12
- Unidentified speaker (speaker_0): need your advice on a stock that's gone down for the past. five
- 31:15
- Unidentified speaker (UNKNOWN): years, over
- 31:16
- Unidentified speaker (speaker_0): 70%. Although
- 31:18
- Unidentified speaker (UNKNOWN): I just
- 31:18
- Unidentified speaker (speaker_0): bought it two years ago,
- 31:20
- Unidentified speaker (UNKNOWN): and
- 31:20
- Unidentified speaker (speaker_0): I bought more on the way down. It seems to have turned the corner lately. It's been up for about the last month.
- 31:27
- Unidentified speaker (UNKNOWN): So
- 31:27
- Unidentified speaker (speaker_0): what do I do now with a stock in this situation? The stock I'm talking about is Nike.
- 31:33
- Unidentified speaker (speaker_3): I think the stock does act better. I know that it's washed out. That's what I would say. It's down forty percent. Both the analysts have turned in already. I don't know how much risk there's left in it. Maybe for it to go back to 3435 on a miss, maybe it goes up to 45 on a on a make. Guess you'll four percent. I think you know what, at this point, washed out. I'm not gonna bet against it. I rather
- 31:53
- Unidentified speaker (speaker_3): unbelievably bet with it. Let's go to Mark in my home state of New Jersey. Mark.
- 31:58
- Unidentified speaker (speaker_0): Booya Booyah, Jim. I go
- 32:00
- Unidentified speaker (UNKNOWN): back
- 32:00
- Unidentified speaker (speaker_0): to the old Kramer uh Cudlo. Cudlow days.
- 32:04
- Unidentified speaker (speaker_3): And
- 32:04
- Unidentified speaker (speaker_0): you have been a great mentor and teacher to me. I have all your
- 32:09
- Unidentified speaker (speaker_0): club member. You've come along, you've helped my retirement tremendously.
- 32:14
- Unidentified speaker (speaker_3): Oh that's
- 32:14
- Unidentified speaker (UNKNOWN): so
- 32:14
- Unidentified speaker (speaker_3): nice. It really is. That's very
- 32:16
- Unidentified speaker (UNKNOWN): nice. Thank you.
- 32:17
- Unidentified speaker (speaker_0): Thank you so much. Um I've got a question for you on Disney. I didn't I didn't bail on it when you advised me to a few months ago and I should have. You see any glimmer of hope with that stock?
- 32:29
- Unidentified speaker (speaker_3): I do. I think this Josh Demorrow is doing very well. I think that the uh I think the cruise line business could be good. I think a lot of people, if you got gasoline down, I think you'd see some better numbers at the club. I like DeMaro. I think he's steady, I think he's good, I think he's doing a great job, and I think you're gonna make money with the stock of the Walt Disney company. All right,
- 32:49
- Unidentified speaker (speaker_3): if you're looking for opportunities outside of tech. I think consumer retail stocks are a good place to go right now. Much more made money at including my exclusive with Hinge Health. Then it was another big day for deals in this market. I'm digging deeper into what's at stake in today's merger analysis. Why the market seems less than enthused with one of them, to say the least. And all your calls, Rapid Fire in tonight's edition of
- 33:09
- Unidentified speaker (speaker_3): the Lightning Round. So stay with Kramer.
- 33:19
- Unidentified speaker (speaker_3): After the bell, we got a strong beat and raise from Hinge Health. That's a digital health platform that's using technology, change how people get physical therapy, manage pain. Members receive personalized exercises, movement feedback, access to clinicians through an app with an in-person network called Hinge Select when face-to-face treatment is needed. Now this time is has already had an extraordinary run, more than
- 33:39
- Unidentified speaker (speaker_3): tripling from its IPO price, which we liked very much last year, gained more than 150% over the past six months. Today's results, solid. Revenue in the third quarter jumped 52% to $235 million, beating expectations. Earnings came in 13 cents ahead of estimates. Magic also delivered better than expected fourth quarter guidance and raises for your sales and profit
- 33:59
- Unidentified speaker (speaker_3): forecasts. forecast. So can the stock keep running with those fantastic numbers? Let's check in with Daniel Perez, he's Hinge Health's co-founder and CEO to learn more about the quarter. Mr. Perez, welcome back to May of Money.
- 34:09
- Unidentified speaker (UNKNOWN): Thanks
- 34:09
- Unidentified speaker (speaker_1): for having me, Jim.
- 34:10
- Unidentified speaker (speaker_3): Okay, so uh let's talk about what I thought is really incredible, which is your it's something I usually don't start with gross margins, but it's very rare that I see so many more people come into a system and yet gross margins went up very big. How can management get a better experience? at lower costs?
- 34:29
- Unidentified speaker (speaker_0): Well, look, we've had this past quarter insatiable demand from our clients, insatiable demand from members to sign up for our program. And we've been able to keep costs down. But we've closed more clients this year than all of last year combined. And we've also had more clients switch to us from competitors this year than probably every year
- 34:49
- Unidentified speaker (speaker_0): combined in our history. So it's just been a phenomenal sales season. We're also having more people enrolled than ever before. And because technology delivers such a big portion of our care, as our client base has grown and our member base has grown, our costs have not grown anywhere near as large.
- 35:05
- Unidentified speaker (speaker_3): Now, you did a fantastic study since I've seen you last, which is a study of over 200,000 participants, nearly 1,000 employers, where you get a return on investment. for the employers and a savings for individuals that I find extraordinary. Maybe you can flush them out for us.
- 35:21
- Unidentified speaker (speaker_0): Yes, look, we we give people better access in our core product of physical therapy, guiding people through their exercises right from the comfort of their own home. They could speak to a physical therapist uh whenever they want. So we could escalate them to physical therapists, therapist, even to doctors when needed, and refer them for in-person care. And when we make access to conservative methods,
- 35:38
- Unidentified speaker (UNKNOWN): we have to use the
- 35:39
- Unidentified speaker (speaker_0): management care for backdriven and muscle pain more convenient, more accessible, lower cost, and more effective, downstream healthcare costs go down. And so we're able to demonstrate a very strong ROI that is a reduction in downstream healthcare spend, predominantly driven by lower utilization of elective surgeries, fewer um
- 35:58
- Unidentified speaker (speaker_0): imaging such as MRIs, fewer joint injections, and that's driving really strong. um outcomes for our members, but also lower costs for our customers.
- 36:06
- Unidentified speaker (UNKNOWN): Right
- 36:06
- Unidentified speaker (speaker_3): now, you made an acquisition, uh, the cylinder acquisition, uh, which takes you beyond muscles and joints to digestive health, again, using some of modern technology, including your iPhone, to do things I never thought possible.
- 36:22
- Unidentified speaker (speaker_0): Look, our overall vision at Hinge Health is to use technology to scale and automate care delivery. Healthcare costs continue to go up. It's like every year, Jim, it's like groundhog day. Hey, guess what? Healthcare costs are going up again. Hey, guess what? It's going up twice the rate of inflation or going up twice as fast as salaries are going up. And we've just like accepted as sure as the sun will
- 36:42
- Unidentified speaker (speaker_0): come up in the morning, healthcare costs will go up. And if we're going gonna to lower healthcare costs, it's going to require technology-driven automation. And that's how we're doing. at Hinge Health. We started in physical therapy and we've demonstrated we could automate about 95% of human clinician hours associated with aspects of outpatient physical therapy. We've since expanded
- 37:01
- Unidentified speaker (speaker_0): into migraine, and we've had a phenomenal uptake from our client base for migraine. And now we're moving into gastrointestinal care as well. And we want to continue to apply technology, both software and connected hardware, to automate care delivery so we could deliver. great outcomes, a great patient experience, and reduce costs. All three aspects of the triple aim, and that's what will ensure that we're successful
- 37:21
- Unidentified speaker (UNKNOWN): long term. But
- 37:22
- Unidentified speaker (speaker_0): if we don't automate care, we won't lower costs.
- 37:24
- Unidentified speaker (UNKNOWN): I agree.
- 37:25
- Unidentified speaker (speaker_3): Now you did mention migraine. That is my area. I used to be the spokesperson for the American Migraine Foundation. I checked in with what you're offering including the ENSO, the wearable pain relief technology, and didn't see a lot of uh let's say uh didn't see a lot of clinician, didn't see a lot of peer papers on it. Not sure w how you know
- 37:45
- Unidentified speaker (speaker_3): that it necessarily is good uh does a good job for patients.
- 37:50
- Unidentified speaker (UNKNOWN): Great
- 37:50
- Unidentified speaker (speaker_0): question. We actually just received FDA clearance for a migraine enzo for migraine product in um in April. ENZOs are Our electrical nerve stimulation device that helps quiet down the nerves that are overactive in migraine. We just launched it um in late spring, early summer, and we've had a phenomenal uptake from enterprise customers. We now have over 800 enterprise customers who are making it available
- 38:10
- Unidentified speaker (speaker_0): to their employees and the members of their plan. About 10 million US adults will have access to our migraine care program from one-one. And we have really, really strong initial results, demonstrating about a 23% reduction in monthly migraine days. And for those who do have migraine using our product, we're reduced. reducing the length of a given migraine attack by about
- 38:30
- Unidentified speaker (speaker_0): 28%. We're actually going to be submitting for publication this quarter, and we're aiming to have our published results out in 2027. So
- 38:38
- Unidentified speaker (UNKNOWN): we're going to do that. That'd be perfect
- 38:39
- Unidentified speaker (speaker_3): to see. I also wanted to know, um, let's say someone is interested in taking Nerdek, which is a pill that gets It rid of my migraines after migraine about after about seven, eight, ten minutes, or Amovic, a shot that I take once a month that also precludes migraine.
- 38:55
- Unidentified speaker (speaker_3): If you're in the program, the migraine program and you know about these, can you be referred to get these products?
- 39:02
- Unidentified speaker (speaker_0): Absolutely. And so there are really good drugs out there for migraine. You know, they don't come without side effects and can be also very, very expensive. Our aim is to give people another tool in their arsenal such that you know they have another non-pharmaological non-pharmacological option for their migraine relief, but it's not in in lieu of of their of any sort of pharmacy option that they might have. But
- 39:22
- Unidentified speaker (speaker_0): we hope to give people an option that doesn't come with the side effects of a lot of these pharmaceutical drugs. And it's a, but it's certainly certainly something that could complement it. And yes, our care team is able to help people manage their drugs. And we're actually going to be adding additional neurologists to our care team as well in the coming months, such that we could even prescribe drugs to Novo and help people manage their medications, potentially even
- 39:42
- Unidentified speaker (speaker_0): switching to lower colour.
- 39:45
- Unidentified speaker (speaker_3): Last thing, uh has Dr. Oz checked in with you? I mean, you're you can save the system so much more. You're doing it the right way in uh by by going to corporations, by going to individuals. But I keep thinking that if they knew your method, they we would finally get some health care costs under control.
- 40:01
- Unidentified speaker (UNKNOWN): Um,
- 40:02
- Unidentified speaker (speaker_0): you know, we we
- 40:09
- Unidentified speaker (speaker_0): We haven't been as active with original Medicare just yet. I know there's a lot going on in Washington. We've been very busy on the private sector, and uh I I don't make many trips to Washington, D.C.
- 40:21
- Unidentified speaker (speaker_3): I think the private sector is the edge in these things, but that's just me personally. That's Daniel Perez, the co co-founder founder of CEO and of. Hinge Health with another unbelievable quarter. We've liked your stock. Seems dirty, and it was a sleeper. Sometimes that's the best way to do it. Thank you so much, Daniel. Good to see
- 40:35
- Unidentified speaker (UNKNOWN): you. Thank you,
- 40:36
- Unidentified speaker (speaker_0): Janet. Mid
- 40:37
- Unidentified speaker (speaker_3): money's back in for the bike.
- 40:39
- Unidentified speaker (speaker_1): Coming up, he's the fastest mind on Wall Street. So we're putting him to the test with your help. Bring on the lightning round. Next.
- 40:55
- Unidentified speaker (speaker_3): It is time for the light room clearly. It's a graphical code.
- 41:02
- Unidentified speaker (speaker_3): You play the sound.
- 41:04
- Unidentified speaker (UNKNOWN): And
- 41:05
- Unidentified speaker (speaker_3): then the lightning round is over. Are you ready, Steve? Doctor Lightroom Cleaner. Let's start with Randy in Texas. Randy.
- 41:13
- Unidentified speaker (UNKNOWN): Hey, Jam. Jim. Watch Watched it. you
- 41:15
- Unidentified speaker (speaker_1): for years and really appreciate all you do and all your
- 41:17
- Unidentified speaker (UNKNOWN): advice here
- 41:18
- Unidentified speaker (speaker_1): to everybody. Hey uh my family and I have both worked and invested in Johnson Johnson for about 30 years and always been happy with the company. How do you foresee that company doing in the next say next year or two as compared to some of
- 41:32
- Unidentified speaker (UNKNOWN): the other people? I think
- 41:33
- Unidentified speaker (speaker_3): this Joaquin Duado is a fantastic CEO. I see many more good things on the horizon, including when they get rid of the uh commodity-based uh uh synthetic joint stuff that I don't want to own because I think it's too low multiple orthopedics. Goodbye, J and J, hello. Own the stock. Robbie in
- 41:53
- Unidentified speaker (speaker_3): California, Robbie.
- 41:55
- Unidentified speaker (speaker_1): Shimbo, thanks for taking my call. Let's make it quick and simple.
- 41:58
- Unidentified speaker (UNKNOWN): I
- 41:58
- Unidentified speaker (speaker_1): got a NeoCloud Neo Cloud here, down 40%. It's the best in the class.
- 42:03
- Unidentified speaker (UNKNOWN): They
- 42:03
- Unidentified speaker (speaker_1): just secured a $3.5 billion loan with Citibank.
- 42:07
- Unidentified speaker (UNKNOWN): Uh
- 42:07
- Unidentified speaker (speaker_1): average analyst targets 243.
- 42:10
- Unidentified speaker (UNKNOWN): Let's
- 42:10
- Unidentified speaker (speaker_1): talk about Nibbius.
- 42:12
- Unidentified speaker (UNKNOWN): I
- 42:12
- Unidentified speaker (speaker_3): think the analysts are wrong. I think that that's the kind of company that if you see NVIDIA going down like this, I can only tell you what that Nibbius should be Nidius should be going down twice as fast. We have high-quality high quality tech stocks that go down every single
- 42:26
- Unidentified speaker (UNKNOWN): day.
- 42:27
- Unidentified speaker (UNKNOWN): And
- 42:28
- Unidentified speaker (speaker_3): Nebius is not high quality. Sorry, not everything can be high quality. Not everything. Let's go to Sam in Massachusetts. Sam.
- 42:37
- Unidentified speaker (speaker_1): Jim, listen, KLA Corp has got a 10-year kager of 30%. The stocks recently have been down, but what's interesting is that it specializes in optical wafer uh equipment, which is, you know, everyone knows there's a full market going on in optical, and I think that's a that should continue to fuel growth for KLA.
- 42:53
- Unidentified speaker (UNKNOWN): Yeah, but you know what?
- 42:54
- Unidentified speaker (speaker_3): This what we had was we didn't get the big guide ups from these companies. Now, my favorite is Lamb Research. That's a 23 times earnings. I'm not gonna stick my head in that line, then. These stocks are in free fall. We don't buy free fall. We don't we're not do we look like butcher block. Do I look like a butcher Bunch block? of I don't see myself as a butcher bush block. Because the stocks will tell us. They will tell us when they're gonna stop
- 43:14
- Unidentified speaker (speaker_3): going down. and I will tell you. It's something that I've done for 45 years, and the stocks have not bought them yet. Let's go to Jack in Ohio. Jack.
- 43:23
- Unidentified speaker (UNKNOWN): Hi,
- 43:23
- Unidentified speaker (speaker_1): Jim. Big booze out of you and your staff for all you
- 43:26
- Unidentified speaker (UNKNOWN): do.
- 43:27
- Unidentified speaker (speaker_3): Thank
- 43:27
- Unidentified speaker (UNKNOWN): you.
- 43:30
- Unidentified speaker (speaker_1): Stock I'm calling about today. I've had for a while. I've got a significant position. It's I've taken a big hit, but now it's on the rebound.
- 43:38
- Unidentified speaker (UNKNOWN): My
- 43:38
- Unidentified speaker (speaker_1): question. is, and by the way,
- 43:40
- Unidentified speaker (UNKNOWN): I'm
- 43:40
- Unidentified speaker (speaker_1): on the house's money. I've sold my cost basis out on me. Okay.
- 43:44
- Unidentified speaker (speaker_3): Good to know, huh?
- 43:45
- Unidentified speaker (speaker_1): We're talking about
- 43:45
- Unidentified speaker (UNKNOWN): how
- 43:46
- Unidentified speaker (speaker_1): Matt Aerospace.
- 43:47
- Unidentified speaker (speaker_3): Oh, I like how much come down a great deal, and the numbers continue to be good. I think you have a good one. It's a not technology stock. It just happens to be a little bit higher moldable, but I like it because it's come to uh it's just been eviscerated. Let's go to Ron and Marilyn. Ron.
- 44:02
- Unidentified speaker (UNKNOWN): Hi.
- 44:02
- Unidentified speaker (speaker_1): Jim. This is Ron from Maryland. And first of
- 44:04
- Unidentified speaker (UNKNOWN): all,
- 44:05
- Unidentified speaker (speaker_1): me and my wife love you.
- 44:06
- Unidentified speaker (speaker_3): Um I've
- 44:07
- Unidentified speaker (speaker_1): done extensive research into Western Digital and bought a ton of it, and I mean a ton, and I plan to hold it for two to three years. First of all, how do you feel about Western Digital? And did I make the right move?
- 44:19
- Unidentified speaker (speaker_3): Well, look, I've known Western Digital for many, many years. I think it's a good company, but I think Micron's a better company. Micron's got a lot more technology. I think that's the one I'd be. in. But I hear you, your stock has gone from 799 to 338. I think it's already been cut in half. It can still fall a little. I like Microb more though. And that, ladies and gentlemen, conclusion of the Lightning Round.
- 44:40
- Unidentified speaker (UNKNOWN): The
- 44:41
- Unidentified speaker (speaker_3): Lightning Round is sponsored by Charles Schwab.
- 44:46
- Unidentified speaker (speaker_3): Coming up, a pair of mergers has Kramer cheering on this Monday. He's breaking them down. Next
- 45:01
- Unidentified speaker (UNKNOWN): The
- 45:01
- Unidentified speaker (speaker_3): start of a fabulous new merger and the finish line of another great one. That's how I felt when I sat back this morning to ponder Marvell Technology's monster $115 billion deal for Lumentum. as well as the long awaited closing of Kimberly Clark's acquisition of Kenview, the former consumer health business of Johnson Johnson.
- 45:21
- Unidentified speaker (speaker_3): You might ask how I can celebrate a tech deal that produces hideous declines for the acquirer, and even worse, the target, as was the case with the Marvell Lumentum tie-up.
- 45:31
- Unidentified speaker (UNKNOWN): Well,
- 45:31
- Unidentified speaker (speaker_3): I would point out that Marvell Marvel CEO Matt Murphy has done five major takeovers since taking the helmet the company 10 ten years ago. You've made money buddy with Marvell everyone. every time. Here's the merger magic. And I think this one, which combines two companies to be the connective tissue in the data center, makes so much sense, so logical, that it's only a matter of time before you see the gains. Oh, but this market is
- 45:51
- Unidentified speaker (speaker_3): short on time, and this particular deal, potentially one of the ten largest mergers in history, might take 18 months to complete. Or even longer. So you can suffer from what we call merger purgatory. In that sense, if you can't stomach that idea, maybe you can't get to sell Marvell and then buy it back later. Now look, I'm willing to recommend that. Uh you know, I don't believe in trading. But I do believe that a company that combines custom
- 46:11
- Unidentified speaker (speaker_3): semiconductors with fiber optic lasers to move data around in a fast and cooler fashion than copper is a company that could be worth double Marvell's current value over the long haul. Hey, look, never forget that Jensen Wong, the CEO of NVIDIA, anointed Marvell as the next trillion dollar company and Matt intends to fulfill that promise. Kimley Clark,
- 46:30
- Unidentified speaker (UNKNOWN): a
- 46:30
- Unidentified speaker (speaker_3): heck of a lot easier to explain. And in many ways it's better because it's so simple. You have a storied tissue and diaper company that stopped growing a long, long time ago. It's been more abundant, no one seemed to care. Then Michael Michael Shu came in, became CEO in twenty nineteen, and began to fix things up for growth. But the portfolio simply wasn't special enough to give you long-term quality growth.
- 46:51
- Unidentified speaker (speaker_3): So in 2025, he decided to purchase Kenview, which was left with a bit of a cats and dogs portfolio after being spun out by JJ, which wanted to concentrate on high growth pharmaceuticals. They have a higher PE multiple. Now, this KenView had a
- 47:03
- Unidentified speaker (UNKNOWN): big
- 47:03
- Unidentified speaker (speaker_3): price tag: $48.7 billion. But the brands, they're all slower growing household brands, but you know a band-aid, Tyler, Tylenol, News Virginia, Listerine, they can be quickly integrated into Kimberly's Worldwide sport wide Portfolio. The transaction should immediately catalyze growth, especially in the club and e-commerce channels where Kenview was particularly weak. There will also be a huge cost
- 47:23
- Unidentified speaker (speaker_3): takeout. I think they got a real bargain, a steal, because RFK Jr., the Secretary of Health and Human Services, have been making these claims about Tylenol during pregnancy increasing the risk of autism. There's never been a causal link over that established about that. But the claim brought Kenview's stock down to where. I think Kimberly got a momentary bargain and it pounced.
- 47:43
- Unidentified speaker (UNKNOWN): We own
- 47:43
- Unidentified speaker (speaker_3): Kimberly Clark for the Travel Trust, which you can follow by joining the CBC Investing Club. It's got a bountiful 4.7% yield. Mike told us this morning on Squalk on the Street that the dividend will be preserved while the company can also quickly pay down debt that it incurred for the Kenview takeover. I like that. Look, obviously the Marvell Momentum tie-up is a much bigger deal. You will have to wait a very long time. to see the
- 48:03
- Unidentified speaker (speaker_3): results play out. But I bet it will soar when the two come together and deal closes, because it represents the future of the data center and they're not going away. I think the stocks went down because the market has no patience for all the months needed to close the transaction. Oh, but and of course the market hates semiconductors. I get that. Nevertheless, there will come a time when this deal will look like all the other deals that
- 48:23
- Unidentified speaker (speaker_3): Matt Murphy has done, and this $150 billion company will be well won. on its way to a trillion dollar valuation. Yeah, the one that Jensen Wong predicted.
- 48:34
- Unidentified speaker (speaker_3): Probably find just for your man money. I'm Drew Kramer.
- 48:45
- Unidentified speaker (speaker_1): CBC or its parent company or affiliates and may have been previously disseminated by Kramer on television, radio, internet, or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his
- 48:57
- Unidentified speaker (speaker_1): opinion.com CNBC.com forward slash madmoney disclaimer. How does Edward Jones do money differently?
- 49:15
- Unidentified speaker (speaker_2): Our financial advisor would listen to us and actually really get to the meat and potatoes of what our lifestyle is and what we believe in. Knowing our financial advisor was always there. We could call him with anything at any time.
- 49:31
- Unidentified speaker (speaker_1): We do money differently by providing advice that actually fits you.
More from Mad Money w/ Jim Cramer
Mad Money: Wall Street Jargon, Cyclicals, GARP & Corrections 11/13/26
Episode discussion: Jim Cramer distinguishes cyclical from secular stocks and advises against holding REITs amid rate hikes
Speakers’ claims: Jim Cramer demystifies Wall Street jargon by contrasting cyclical stocks tied to economic cycles with secular growth companies that perform regardless of economic conditions. He recommends higher equity exposure for younger investors and suggests dollar-cost averaging into S&P 500 index funds for long-term goals. Cramer warns against holding REITs due to interest rate pressure and cautions investors against turning failed trades into long-term investments. He advocates for diversification, limiting any single sector to 20% of a portfolio, and emphasizes management execution over passive buy-and-hold strategies.
NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26
Episode discussion: Cramer on NVIDIA CEO Exit, Anthropic IPO Risks, and Moderna's Cancer Vaccine Breakthrough
Speakers’ claims: Jim Cramer discusses the resignation of NVIDIA CEO Jensen Huang amid security and personal scandals, advising investors to take profits despite the company's strong fundamentals. He analyzes Anthropic's upcoming IPO, highlighting concerns about share unlock dynamics and pricing pressure compared to its massive cash balance. The episode also covers Kraft Heinz's strategic pivot away from a corporate split toward innovation and digital marketing. Finally, Cramer highlights Moderna's stock surge following positive melanoma vaccine data and details the company's personalized cancer treatment technology.